Process Control Software
Search Within Results
1
–
8
of
8
results
1
Comecerbrand SpeedyGlove Management and Control Software SLA - Yearly License Fee
Service Level Agreement. MANDATORY.
2
Medchemexpress LLC LHC-165 | 1258595-14-0 | 98.0% | 603.55 | 10 MG
LHC-165 is a TLR7 agonist with potential for use in the study of solid tumors. It is for research use only and not sold to patients.
- Target: TLR7
- Molecular weight: 603.55
- Formula: C29H32F2N3O7P
- Appearance: Solid
- Color: Light yellow to yellow
- Solubility (in vitro): 1M NaOH: 50 mg/mL (82.84 mM; ultrasonic and adjust pH to 12 with NaOH)
- Shipping: Room temperature in continental US; may vary elsewhere
- Storage: -20°C, stored under nitrogen. In solvent: -80°C for 6 months; -20°C for 1 month (stored under nitrogen)
- Disease areas: Cancer, Cancer immunotherapy
- Immunology/inflammation: Toll-like receptor (TLR)
3
SENSOTECH INC LIQUISONIC CONTROLLER 20 V10
- 1 channel
- 1 measured component
- High-resolution TFT touch display
- Multilingual user guidance, virtual keyboard
- Ingress protection: IP65 (front)
- Mounting options: Wall mount, Rack mount (19 in), Field housing
- Data storage: 2 GB SSD
- 4-20 mA analog outputs
- 4-20 mA analog inputs
- Digital inputs: true
- Digital outputs: true
- Communication interfaces: Ethernet, RS232, USB
- Optional fieldbus: Profibus, Modbus, TCP
- Password-supported user management
- Special functions: Multichannel trend display, SonicGraph acoustic signal display
- Remote control: Via browser with PC or tablet
- Measurement principle: Ultrasonic velocity
- Typical measurement accuracy: 0.05% to 0.1% (system)
- Low maintenance
4
5
6
7
Medchemexpress LLC LHC-165 | 1258595-14-0 | 98.0% | 603.55 | 100 MG
LHC-165 is a TLR7 agonist with potential for use in the study of solid tumors. This compound is designed for research applications, particularly in immunology and cancer studies.
- Functions as a TLR7 agonist
- Potential for use in the study of solid tumors
- Targets Toll-like Receptor (TLR)
- Related to Immunology/Inflammation pathways
- Store at -20°C under nitrogen
- Soluble in 1M NaOH at 50 mg/mL
8
Medchemexpress LLC LHC-165 | 1258595-14-0 | 98.0% | 603.55 | 25 MG
LHC-165 is a TLR7 agonist that shows potential for use in the study of solid tumors.
- Targets TLR7
- Potentially applicable for solid tumor studies
- Purity is 98.0%
- Appears as a solid, light yellow to yellow substance